MARKET

APM

APM

Aptorum Group Ltd
NASDAQ
0.8381
-0.0919
-9.88%
After Hours: 0.8305 -0.0076 -0.91% 19:33 03/30 EDT
OPEN
0.9600
PREV CLOSE
0.9300
HIGH
0.9600
LOW
0.8381
VOLUME
61.37K
TURNOVER
--
52 WEEK HIGH
4.470
52 WEEK LOW
0.6500
MARKET CAP
6.83M
P/E (TTM)
-0.9006
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at APM last week (0323-0327)?
Weekly Report · 22h ago
Aptorum FY2025 net loss narrows 66.9% to $1.4 million; revenue posts no revenue
Reuters · 3d ago
Aptorum amends Form 6-K; merger termination date extends to June 30, 2026
Reuters · 4d ago
Weekly Report: what happened at APM last week (0316-0320)?
Weekly Report · 03/23 10:15
Weekly Report: what happened at APM last week (0309-0313)?
Weekly Report · 03/16 10:14
Aptorum Group, DiamiR announce publication of microRNA biomarker study
TipRanks · 03/10 12:26
APTORUM GROUP AND DIAMIR BIOSCIENCES ANNOUNCE PUBLICATION OF MICRORNA GLIOBLASTOMA BIOMARKER STUDY IN DIAGNOSTICS IN COLLABORATION WITH THE UNIVERSITY OF PENNSYLVANIA
Reuters · 03/10 12:00
Weekly Report: what happened at APM last week (0302-0306)?
Weekly Report · 03/09 10:14
More
About APM
Aptorum Group Limited is a United Kingdom-based clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. Its lead projects are ALS-4, SACT-1 and PathsDx Test. ALS-4 is a small drug molecule which appears to target the products produced by bacterial genes that facilitate the successful colonization and survival of the bacterium in the body or that cause damage to the body's systems. SACT-1 is the first repurposed drug candidate to be developed under the Smart-ACT drug discovery platform. The Company's pipeline is also enriched through the co-development of PathsDx Test, a molecular-based rapid pathogen identification and detection diagnostics technology, with Accelerate Technologies Pte Ltd, the commercialization arm of the Singapore's Agency for Science, Technology and Research.

Webull offers Aptorum Group Ltd stock information, including NASDAQ: APM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading APM stock methods without spending real money on the virtual paper trading platform.